02:31 , May 18, 2018 |  BC Week In Review  |  Company News

Illumina shells out $100M for Edico Genome acquisition

Illumina Inc. (NASDAQ:ILMN) will acquire genome analytics company Edico Genome Inc. (La Jolla, Calif.) for $100 million. SVP of Product Development Susan Tousi told BioCentury that Illumina will use Edico's DRAGEN Bio-IT Platform to accelerate...
21:44 , May 15, 2018 |  BC Extra  |  Company News

Illumina to acquire Edico for $100M

Illumina Inc. (NASDAQ:ILMN) will acquire genome analytics company Edico Genome Inc. (La Jolla, Calif.) for $100 million. SVP of Product Development Susan Tousi told BioCentury that Illumina will use Edico's DRAGEN Bio-IT Platform to accelerate...
00:03 , Feb 15, 2018 |  BC Innovations  |  Translation in Brief

The DRAGEN and the genome

By analyzing a whole genome in under 30 minutes, Edico Genome’s DRAGEN Bio-IT platform is helping to push Genomics England towards achieving its goal of sequencing 100,000 whole genomes and making genomic sequencing a staple...
01:50 , May 13, 2017 |  BioCentury  |  Finance

Ready to ramp

A day after emerging from stealth mode, strategic investor Dell Technologies Capital backed Edico Genome Inc. to ramp up the launch of a bioinformatics processor used to analyze sequencing data. The VC led Edico’s $22...
21:49 , May 9, 2017 |  BC Extra  |  Financial News

Edico raises $22M in series B

Edico Genome Inc. (San Diego, Calif.) raised $22 million in a series B financing led by new investor Dell Technologies Capital, the venture arm of Dell Technologies Inc. (NYSE:DVMT). Existing investors Qualcomm Ventures, Axon Ventures...
07:00 , Jul 21, 2014 |  BioCentury  |  Emerging Company Profile

Edico: Processing genomes

Next-generation sequencing technologies have reduced the time and cost to sequence whole genomes, but the computational time and resources needed to analyze the resulting data remain a bottleneck. Edico Genome Inc. is developing a processor...
00:23 , Jul 18, 2014 |  BC Extra  |  Financial News

Edico raises $10 million in A round

Edico Genome Inc. (La Jolla, Calif.) raised $10 million in a series A round led by Qualcomm Ventures. Axon Ventures and Gregory Lucier also participated. Edico is developing its Dragen Bio-IT processor, which reduces the...
07:00 , Oct 21, 2013 |  BC Week In Review  |  Company News

Bioceros, 4SC, Genedata, Horizon Discovery cardiovascular, genomics, gene/cell therapy news

The CV genes-at-target consortium led by German Heart Center Munich (Munich, Germany) received a €5.8 million ($7.8 million) grant from the EU's Framework Programme 7 (FP7) to evaluate genomic risk loci for coronary artery disease...
00:52 , Oct 25, 2006 |  BC Extra  |  Company News

BioIT Alliance starts biomarker project

The Microsoft-led Bio IT Alliance launched its Biomarkers Project, a proof-of-concept collaboration that seeks to simplify the process for identifying and validating genetic biomarkers. Agilent (Palo Alto, Calif.), Applied Biosystems (ABI) and Illumina (ILMN) will...
08:00 , Mar 31, 2003 |  BioCentury  |  Emerging Company Profile

Predix: Ferreting out GPCRs

Many companies are pursuing G protein-coupled receptors, but because these proteins are membrane-bound, crystal structures of these targets are rare. Predix Pharmaceuticals Inc. is addressing this issue via computational structure-based discovery. The company originally was...